Apolipoprotein E genotype and odor identification in schizophrenia

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 18, Issue 2, 2006, Pages 231-233

  Moberg, Paul J ^a   Arnold, Steven E ^b   Roalf, David R ^b   Balderston, Catherine C ^b   Abbazia, Jaime ^b   Kohler, Christian G ^b   Gur, Raquel E ^b   Turetsky, Bruce I ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ADULT; ALLELE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC RISK; GENOTYPE; HUMAN; MALE; ODOR; OLFACTORY DISCRIMINATION; PRIORITY JOURNAL; SCHIZOPHRENIA; SMELLING DISORDER; UNITED STATES;

EID: 33646750398     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.2006.18.2.231     Document Type: Article

References (14)

1. Martzke JS, Kopala LC, Good KP: Olfactory dysfunction in neuropsychiatric disorders: review and methodological considerations. Biol Psychiatry 1997; 42(8):721-732
2. Moberg PJ, Turetsky, B.I: Scent of a disorder: olfactory functioning in schizophrenia. Curr Psychiatry Rep 2003; 5:311-319
3. Moberg PJ, Arnold SE, Doty RL, et al: Impairment of odor hedonics in men with schizophrenia. Am J Psychiatry 2003; 160:1784-1789
4. Kopala LC, Good KP, Morrison K, et al: Impaired olfactory identification in relatives of patients with familial schizophrenia. Am J Psychiatry 2001; 158(8):1286-1290
5. Kopala LC, Good KP, Torrey EF, et al: Olfactory function in monozygotic twins discordant for schizophrenia. Am J Psychiatry 1998; 155(1):134-136
6. Murphy C, Bacon AW, Bondi MW, et al: Apolipoprotein E status is associated with odor identification deficits in nondemented older persons. Ann NY Acad Sci 1998; 855:744-750
7. Graves AB, Bowen JD, Rajaram L, et al: Impaired olfaction as a marker for cognitive decline: interaction with apolipoprotein E epsilon4 status. Neurology 1999; 53:1480-147
8. Bacon AW, Bondi MW, Salmon DP, et al: Very early changes in olfactory functioning due to Alzheimer's disease and the role of apolipoprotein E in olfaction. Ann NY Acad Sci 1998; 855:723-731
9. APA: Diagnostic and Statistical Manual of Mental Disorders. Washington, DC, American Psychiatric Association, 1994
10. Arnold SE, Joo E, Martinoli MG, et al: Apolipoprotein E genotype in schizophrenia: frequency, age of onset, and neuropathologic features. Neuroreport 1997; 8:1523-156
11. Doty RL, Shaman P, Dann M: Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiol Behav 1984; 32(3):489-502
12. Malhotra AK, Breier A, Goldman D, et al: The apolipoprotein E epsilon 4 allele is associated with blunting of ketamine-induced psychosis in schizophrenia. A preliminary report. Neuropsychopharmacology 1998; 19:445-148
13. Schurhoff F, Krebs MO, Szoke A, et al: Apolipoprotein E in schizophrenia: a French association study and meta-analysis. Am J Med Genet 119B(1):18-23, 2003
14. Lan TH, Hong CJ, Chen JY, et al: Apolipoprotein E-epsilon 4 frequency in patients with schizophrenia. Biol Psychiatry 42(3):225-227, 1997